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Comparison of the effect of upper body-
ergometry aerobic training vs treadmill training on
central cardiorespiratory improvement and
walking distance in patients with claudication
Ulf Gunnar Bronas, PhD,a Diane Treat-Jacobson, PhD, RN,a and
Arthur S. Leon, MD,b Minneapolis, Minn
Background: Supervised treadmill-walking exercise programs have been proven to be a highly effective in improving walking
distance in peripheral arterial disease (PAD) patients with lifestyle-limiting claudication. Limited information is available on
the contributions of central cardiorespiratory functions for improving these patients’ walking capacity with exercise training.
Methods: This study randomized 28 participants (21 men; age, 65.6 years; 92.7% smoking history, 36.6% with diabetes)
with lifestyle-limiting PAD-related claudication to 3 hours/week of supervised exercise training for 12 weeks, using
arm-ergometry (n 10) or treadmill-walking (n 10) vs a usual-care control group (n 8). Cardiorespiratory function
measurements were assessed before and after training at a submaximal workload and at the onset of claudication
(pain-free walking distance [PFWD]) and at maximal walking distance [(MWD]). Changes in these functions from
baseline were analyzed among the groups with analysis of covariance. Associations between variables were determined by
Pearson’s partial correlations.
Results: The mean baseline demographic, medical, and exercise variables were similar among the groups. There were
similar significant differences in the submaximal double product (heart rate  systolic blood pressure) and at MWD,
ventilatory threshold, ventilatory oxygen uptake (VO2) at onset of claudication, and VO2 peak in response to training in
both exercise groups vs the control group. Statistically significant, moderate correlations (r  0.60-0.68) were found
between changes in all cardiorespiratory variables and changes in PFWD or MWD.
Conclusion: Improvements in cardiorespiratory function after arm-ergometry or treadmill-training were significantly
associated with improvements in both PFWD and MWD, providing supporting evidence of systemic contributions
to exercise training-related improvements in walking capacity seen in patients with claudication. ( J Vasc Surg 2011;
53:1557-64.)
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cPeripheral artery disease (PAD) is a progressive, athero-
sclerotic, occlusive arterial disease, associated with aging, in-
volving themajor arteries of the lower extremities. This disease
affects12% of American adults, results in increased morbid-
ity, reduced functional capacity, and quality of life, and is
associated with premature death frommyocardial or cerebro-
vascular infarction.1-4 Claudication, which occurs in approxi-
mately 4 to 5 million Americans with known PAD, is charac-
terized by walking-induced lower extremity ischemic
muscular pain that severely limits walking capacity and is
associated with reduced physical fitness and related central
cardiorespiratory dysfunctional changes.1,2,5
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doi:10.1016/j.jvs.2011.01.077Numerous investigations have demonstrated the effec-
iveness of repeated intermittent treadmill-walking to the
oint of inducing moderately severe claudication pain as a
herapeutic intervention for significantly improving pain-
ree walking distance (PFWD) and maximal walking dis-
ance (MWD) in individuals with symptomatic PAD.5-8
owever, the mechanisms by which the intervention im-
roves walking capacity have yet to be fully elucidated. It is
ypothesized that the repeated intermittent lower extrem-
ty muscle ischemia caused by walking induces local skeletal
uscle vascular and metabolic adaptations.5,9-11
The potential role of the conditioning effect of walking
xercise on central cardiorespiratory fitness for improving
alking ability in patientswith claudication remains uncertain.
revious studies that evaluated the effectiveness of arm or leg
ycling exercise as a therapeutic intervention in patients with
laudication have demonstrated that both arm or leg cycle
rgometer exercise training improve PFWD and MWD in
AD patients with claudication.12-16 The findings in these
tudies that arm exercise training improves walking ability
upport the contribution of central cardiorespiratory adapta-
ions, rather than just the role of ischemia-induced local mus-
le vascular and metabolic changes.
The purpose of this study was to compare the effective-
ess of 12 weeks of arm-ergometry vs treadmill-walking
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June 20111558 Bronas et alexercise training for improving physical fitness-related cen-
tral cardiorespiratory functions and to determine the asso-
ciation of these functions with improvement in walking
capacity in PAD patients with claudication. We hypothe-
sized that both forms of exercise training would be effective
in improving central cardiorespiratory fitness compared
with a usual-care control group and that this improvement
in fitness would be significantly associated with improve-
ment in walking capacity in PAD patients with claudication.
METHODS
Design. This study was conducted as an ancillary study
of the Exercise Training for Claudication (ETC) Study.16
The ETC study was a single-center, randomized, controlled
trial comparing the relative efficacy of arm-ergometry or
treadmill-walking exercise training vs usual care in improv-
ing walking distance in PAD patients with lifestyle-limiting
claudication. This study was approved by the University of
Minnesota’s Institutional Review Board for Protection of
Human Subjects, and written informed consent was ob-
tained from each participant.
Sample. Participants were recruited through clinician
referrals and advertisements throughout Minneapolis-St.
Paul and the surrounding areas. Screening procedures and
a consort diagram have previously been published.16 Study
participants were eligible for inclusion if they were aged
18 years, had lifestyle-limiting claudication, an ankle-
brachial index (ABI) of0.90, or a 10% decrease in postex-
ercise ABI. All participants had to be able to complete a
treadmill-walking test at 2.0 mph and were able and willing
to participate in a 12-week supervised exercise program.
Exclusion criteria included contraindications to exer-
cise training such as uncontrolled stage 2 hypertension
(defined as 200 mm Hg systolic blood pressure or dia-
stolic blood pressure 100 mm Hg, or both),17 ischemic
leg pain at rest, leg or foot ulcerations or impending gan-
grene, exercise capacity limited by other health problems, a
recent myocardial infarction (6 months) or unstable cor-
onary heart disease, or a coronary or lower extremity revas-
cularization procedure 3 months.
Participants currently taking pentoxifylline or cilostazol
were eligible provided that these medications were initiated
at least 3months before study enrollment. Participants with
well-controlled diabetes were eligible for participation in
accordance with standard diabetic management guidelines
pertaining to physical activity.17 Participants were in-
structed to maintain their usual dietary habits and pre-
scribed medications during the study unless otherwise di-
rected by their physician, and compliance was monitored
throughout the study. There was no specific risk factor
management involved in the study protocol.
A power analysis for samples size determination was
performed based on pilot data of exercise-induced
changes in MWD as the primary outcome variable for
both treadmill-walking and arm-ergometer exercise
training. This analysis indicated that with 28 participants
randomized to either one of the exercise groups or the control group, the study was powered at 0.90 using an 
f 0.05 and an effect size of 1.5.
Procedures. All study procedures were performed in
he Laboratory of Physiological Hygiene and Exercise Sci-
nce at the University of Minnesota. After giving informed
onsent, participants performed a symptom-limited,
raded treadmill exercise test (GXT) to determine their
aseline physical fitness, associated cardiorespiratory func-
ions, and their PFWD and MWD. The protocol for tread-
ill exercise used in this study initiated walking at 2 mph
nd 0% grade for 3 minutes, followed by a progressive
ncrease in grade of 3.5% every 3 minutes, until a grade of
0.5% was obtained. At this stage, the treadmill speed was
ncreased by 0.5 mph every 3 minutes while maintaining
he grade at 10.5%. The increase in rate of energy expendi-
ure using this protocol approximated a 1-metabolic equiv-
lent of task (MET) increase per stage.
Claudication pain was assessed every 30 seconds
hroughout the GXT. The distance walked before the first
nset of claudication was defined as the PFWD, and the
WD was defined as the distance at which the participant
ad to stop because of severe claudication. Participants
ere only permitted to lightly grip the front handrail of the
readmill for balance purposes.18
The intraclass correlation for MWD between repeated
readmill tests 1 week of each test was 0.96. The coeffi-
ient of variation between the two treadmill tests was 10.1%
r 33  12 meters. The treadmill test was preceded and
ollowed by an ABI determination, as previously de-
cribed.16
Participants who continued to meet the inclusion cri-
eria after their initial GXT were scheduled for a second
readmill exercise test following the same protocol. If the
WD for the second GXT varied by 25% from the first
est, a third test was performed. If the MWD of the third
est continued to vary 25% from the previous tests, the
articipant was excluded from the study. This was done to
ontrol for the learning adaptation that may occur in re-
ponse to repeated treadmill exercise testing in PAD pa-
ients and to exclude participants whose walking was lim-
ted by factors other than claudication. Of the participants
hat completed the treadmill test, 27% were excluded for
arious reasons, including pseudoclaudication, or exercise
imited by problems other than claudication.16
The data from the last GXT performed were considered
he baseline measurements. Participants were randomized
o one of the three study groups: arm ergometry, treadmill,
r usual medical care, after completion of baseline assess-
ents. All testing procedures were repeated at the end of
he 12-week intervention period.
Cardiorespiratory measurements during GXTs.
ardiorespiratory fitness was assessed during the symptom-
imited GXT in a postabsorptive state, with no smoking or
affeinated beverages permitted for 8 hours before testing.
uring the maximal GXTs, continuous respiratory gas
xchange measurements were obtained by a calibrated Sen-
ormedics 2900 metabolic cart (Yorba Linda, Calif) with a
ontinuous rolling average of 20 seconds and a mixing
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Volume 53, Number 6 Bronas et al 1559chamber used for analyses of expired gas volumes. Respira-
tory gas exchange measurements were used to calculate
ventilatory equivalents and ventilatory threshold. Ventila-
tory threshold (reflecting the intensity of exercise at which
anaerobic metabolism supplements the rate of aerobic me-
tabolism) was determined using the V-slope method.19,20
Peak VO2 was defined as the average VO2 at the last minute
before MWD was achieved.19,20
Hemodynamic variables. Heart rate and rhythm dur-
ing exercise were continuously monitored during each
GXT. The differences between heart rate at baseline and
after the intervention were used to investigate exercise
training-induced changes in cardiac demands in response to
exercise training. Blood pressure was measured by auscul-
tation during the last minute of each stage of the GXT. The
blood pressure and heart rate were also measured at MWD.
The heart rate  the systolic blood pressure (double prod-
uct), a surrogate measure of myocardial oxygen demands
and coronary blood flow, was calculated during stage 1 (2.0
mph at 0% grade) of the GXT and at MWD.
Arm-ergometer exercise test. A baseline arm-
ergometer exercise test was conducted 1 week of the last
baseline GXT for determination of peak arm exercise capac-
ity. Participants began the exercise at 50 rpm at 10 W,
followed by an increase by 10 W every 3 minutes, until the
study participant could not maintain the required 50 rpm,
because of arm fatigue.
Exercise training programs by study group. Both
exercise training groups reported to the exercise laboratory
three times weekly for 12 weeks of supervised exercise.16
Each training session lasted 60 minutes, including 5 min-
utes of warm-up and cool-down low-intensity exercises
(either slow walking or low-intensity arm ergometry). The
arm-ergometry exercise prescription was designed to pro-
vide a similar relative intensity and volume of exercise
(calculated by METminutes of exercise) as the treadmill
exercise (based on intermittent walking to moderate clau-
dication pain).
Treadmill-walking group. The treadmill-walking
group initiated their exercise program by intermittently
walking at 2 mph at 0% grade, (equivalent to stage 1 of the
treadmill GXT). During the training sessions, participants
continued walking at a given pace until they experienced
moderately severe claudication (rated 3 to 4 on a scale of
0-5). They then stopped and rested (seated) until the pain
completely subsided, at which time they resumed walking
at the same pace. The grade was progressively increased by
0.5% to 1.0% if the participant was able to walk for 8
minutes up to a 10% grade, after which the speed was
increased by 0.1- to 0.2-mph increments as tolerated.16
Arm-ergometry cycle training group. The arm-
ergometry study group initiated their exercise program at a
cycling rate of 50 rpm and 10 W below the maximal level
they achieved during the baseline arm-ergometry test. Par-
ticipants exercised intermittently, beginning with 2-minute
increments of exercise, followed by a 2-minute rest period
for a total exercise duration of 60 minutes per session. The
exercise volume was progressively increased every 2 to 3 ceeks by increasing the duration of the exercise cycles and
ecreasing the resting period, for up to 5 minutes of
ontinuous exercise and 1 minute of rest intervals. Target
xercise intensity was determined by a Borg Rating of
erceived exertion scale of 13 to 15 on a scale of 6 to 20.17
Control group. Participants in the control group
ere instructed to continue to follow the care prescribed by
heir primary physicians. Control participants also received
ritten instructions on how to exercise independently if
hey so chose to do. Similar instructions are commonly
rovided to PAD patients by their physicians. Control
roup participants were also required to visit the exercise
aboratory once each week for the 12-week intervention
eriod to monitor their resting heart rate and blood pres-
ure, assess for any adverse events, and to encourage con-
inued participation in the study.
Monitoring of unsupervised exercise. All partici-
ants, including the control group, were asked to maintain
daily record of any exercise performed independently
utside of the exercise laboratory setting. These records
ncluded the mode, intensity, and time spent exercising in
ddition to the supervised exercise-training program in the
wo exercise groups.
Statistical analysis. Variables were tested for normal-
ty using standard statistical procedures, and descriptive
tatistics of the participants’ characteristics were completed.
hanges with interventions in physical fitness-associated
ardiorespiratory functions during walking exercise testing
ere the primary study end points. Changes in PFWD and
WD during treadmill GXT were secondary end points of
his ancillary study. Baseline values, reported unsupervised
xercise, the use of -adrenergic blocking agents, and
moking status were included as covariates in all analyses of
ovariance (ANCOVA). Most of the study participants had
ot previously participated in a supervised claudication
xercise program. Control participants were considered to
ave performed the usual recommended amount of unsu-
ervised exercise for PAD patients with claudication if they
eported in their daily exercise log any regular moderate-
ntensity aerobic exercise, which generally consisted of
alking for at least 30minutes, three times per week, which
s the usual clinically prescribed exercise program for PAD
atients. The exercise intervention groups were also con-
idered to have performed the usual recommended volume
f exercise, in addition to their supervised exercise, if so
ndicated in their exercise logs.
Owing to large skewed standard deviations in changes
n the PFWD observed in the present study, a logarithmic
ransformation of these data was performed. Submaximal
xercise end point measurements after 12 weeks of inter-
ention were obtained at stage 1 (2.0 mph at 0% grade) of
he symptom-limited treadmill GXT and at the PFWD.
eak exercise duration was defined as the point when study
articipants requested to stop due to severity of claudica-
ion. Analyses included group data from all randomized
articipants enrolled in the study, using the intention-
o-treat principle. Association between respiratory gas ex-
hange measures and the MWD were assessed using indi-
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June 20111560 Bronas et alvidual Pearson product moment correlation coefficients.
The  level for statistical significance was set at 0.05 for all
analyses. All procedures were completed using SPSS 13.0
software (SPSS Inc, Chicago, Ill).
RESULTS
Participant characteristics. Participant characteristics
at baseline are presented in Table I. There were no signifi-
cant mean differences between the three study groups in
medical variables, including, smoking history, diabetes
prevalence, or in PAD severity as assessed by resting ABI at
baseline. Demographics of the participants enrolled in the
present study were similar to those reported in previous
exercise intervention studies involving patients with PAD
and claudication.5-7,9,10,12,13 Participant adherence to
training was excellent: 97% of both groups of exercise
training participants completed at least 75% of their 36
prescribed training sessions. The most common reasons for
reduced adherence were illness, scheduling conflicts, and
transportation difficulties.
Resting hemodynamic variables. No significant differ-
ences among the study groups were observed in mean
baseline and postintervention resting diastolic blood pres-
sure, heart rate, or resting ABI. Resting systolic blood
pressure level was significantly lower after 12 weeks of
exercise training only in the arm-ergometer group com-
pared with the control group (P  .048); however, no
significant difference was observed between the exercise
Table I. Demographics and medical variables of study par
Variable
Arm ergometry
(n  10)
Mean (SD)
Age in years 64 (8.6)
Pack years 45.6 (24.8)
Lowest resting ABI 0.66 (.15)
BMI kg/m2 29.9 (8.8)
PFWD 133 (64)
MWD 421 (189)
No. (%)
Male 8 (80)
White race 9 (90)
Diabetes 6 (60)
Current/past smoking 10 (100)
Dyslipidemia 10 (100)
Hypertension 7 (70)
Prior leg revascularization 2 (20)
Coronary heart disease 7 (70)
Current medicationsa
Cilostazol 2 (20.0)
Antiplatelet agent 10 (100.0)
Lipid-lowering agent 9 (90.0)
-blocking agent 5 (50.0)
ACE inhibitor 7 (70.0)
ABI, Ankle-brachial index; ACE, angiotensin-converting enzyme; BMI, bod
pain-free walking distance.
aNo significant differences between groups by 2 or t tests.groups. IPostintervention submaximal hemodynamic and
espiratory gas exchange measurement changes. The
ouble product during submaximal (2.0 mph at 0% grade)
xercise decreased significantly in both exercise training
roups compared with the control group, with no signif-
cant difference observed between the exercise groups
Table II). There were no significant changes in heart
ate (P  .064), blood pressure (P  .071), or respira-
ory gas exchange measurements, as assessed during
tage 1 of the GXT. However, the rate of oxygen con-
umption at the onset of claudication increased signifi-
antly (P  .030), with an associated reduction in VE/
O2 (P  .047) from baseline to 12 weeks in both
xercise groups compared with the control group; again,
o significant difference was observed between exercise
roups. A significant increase in mean rate of VO2 at the
entilatory threshold during submaximal exercise testing
as observed in the treadmill and arm-ergometer
roups, but not in the control group, with no significant
ifferences between the exercise intervention groups
Table II).
Changes in postintervention peak hemodynamic
nd respiratory gas exchange measurements. There was
significant increase in mean change in peak levels of heart
ate, double product, VO2, and minute ventilation in both
xercise intervention groups compared with the control
roup, but again, there were no significant differences
etween the two exercise groups (Tables III and IV).
nts
admill walking
(n  10)
Mean (SD)
Control
(n  8)
Mean (SD)
Total
(n  28)
Mean (SD)
63 (11.5) 70 (7.8) 65.6 (8.5)
49.2 (35.9) 36.4 (21.6) 43.7 (27.1)
0.68 (.11) 0.69 (.15) 0.68 (0.1)
26.4 (3.3) 29.2 (5.4) 28.5 (4.3)
199 (159) 106 (56) 149 (111)
490 (305) 357 (177) 428 (233)
No. (%) No. (%) No. (%)
6 (60) 7 (88) 21 (75)
11 (100) 6 (75) 26 (93)
1 (9) 3 (37) 10 (35)
10 (100) 7 (88) 27 (96)
8 (80) 6 (75) 24 (79)
8 (80) 7 (88) 22 (80.5)
3 (30) 3 (38) 8 (29)
6 (60) 4 (50) 17 (61)
3 (27.3) 0 (0.0) 5 (18)
8 (80) 6 (60) 24 (86)
7 (70) 4 (50.0) 20 (71)
3 (30) 4 (50.0) 12 (43)
3 (30) 1 (10) 11 (39)
s index;MWD,maximum walking distance; SD, standard deviation; PFWD,ticipa
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Volume 53, Number 6 Bronas et al 1561tory variables was further supported by the finding of a
significant increase in mean peak MET level (multiples of
resting energy expenditure) achieved during the GXT from
baseline to 12 weeks in the arm-ergometer and treadmill-
walking exercise groups, but not in the control group;
again, with no significant difference observed between the
two exercise groups (Table IV).
Change in walking distances. From baseline to 12
weeks, there was a significant 89.6  74-meter (82%)
Table II. Change in selected submaximal hemodynamic a
Double product (HR  SBP) ANCOVA
V
(m
Groupa Baseline
Change at
12 wks
F  5.29;
P  .006 Baseli
AE 16,372 (6550) –3847 (5427) .046 vs
controlb
10.1 (2
TM 14,257 (3246) –2034 (3680) .033 vs
controlb
10.4 (3
Control 14,304 (3865) 1291 (4594) . . . 10.1 (4
AE, Arm ergometer; ANCOVA, analysis of covariance HR, heart rate; PFW
oxygen consumption, VT, ventilatory threshold.
aData are presented as mean (standard deviation).
bPost hoc analysis with Bonferroni adjustment for multiple comparisons, no
Table III. Change in selected peak exercise hemodynamic
Peak exercise HR (bpm) ANCOVA Peak exercise S
Groupa Baseline
Change at
12 wks
F  5.676;
P  .010 Baseline
AE 118.3 (20.7) 9.7 (18.9) .025 vs
controlb
168.7 (32.8)
TM 123 (18.4) 8.7 (14.6) .016 vs
controlb
165.9 (32.3)
Control 114.9 (14.3) 	4.6 (9.9) 168.8 (25.1)
AE, Arm ergometer;ANCOVA, analysis of covariance;HR, heart rate; SPB,
threshold.
aData are presented as mean (standard deviation).
bPost hoc analysis with Bonferroni adjustment for multiple comparisons no
Table IV. Change in selected peak exercise respiratory var
Peak exercise VO2,
mL/kg/min ANCOVA Peak exe
Groupa Baseline
Change at
12 wks
F  3.329;
P  .047 Baseline
AE 14.9 (2.9) 1.47 (1.9) .030 vs
controlb
44.3 (11.9)
TM 14.1 (2.9) 1.49 (1.7) .033 vs
controlb
35.8 (12.9)
Control 13.4 (2.0) 	0.38 (2.0) 39.4 (8.6)
AE, Arm ergometer; ANCOVA, analysis of covariance; TM, treadmill; VO2
metabolic equivalent.
aData are presented as mean (standard deviation).
bPost hoc analysis with Bonferroni adjustment for multiple comparisons, nomean increase in the PFWD in the arm-ergometer group eP  .004) and a 106.7  147-meter (62%) mean
ncrease in the treadmill-walking (P  .048) exercise
raining groups, with a 7.3  43.8-meter (2.8%) change
oted in the control group, which was not significant.
ollowing logarithmic transformation, a statistically sig-
ificant increase in the PFWD was observed in the arm-
rgometer (P  .004) and treadmill-exercise (P  .028)
raining groups compared with the control group, with
o significant differences observed between the two
spiratory variables from baseline to 12 weeks
FWD
g/min) ANCOVA
VO2 at VT,
mL/kg/min ANCOVA
Change at
12 wks
F  4.114;
P  .030 Baseline
Change at
12 wks
F  4.114;
P  .030
1.71 (2.4) .011 vs
controlb
8.5 (3.7) 4.8 (3.4) .038 vs
controlb
1.17 (3.0) .033 vs
controlb
8.4 (3.7) 5.5 (4.0) .011 vs
controlb
–.28 (4.1) . . . 9.8 (3.3) –1.30 (4.1)
in-free walking distance; SBP, systolic blood pressure; TM, treadmill; VO2,
ficant difference between groups.
ables from baseline to 12 weeks
m Hg ANCOVA
Peak exercise double product,
HR  SBP ANCOVA
nge at
wks
F  .443;
P  .648 Baseline
Change at
12 wks
F  3.944;
P  .001
(30.5) 20,400 (7185) 4483 (4092) .05 vs
controlb
(36.8) 20,673 (5817) 3651 (4151) .01 vs
controlb
(22.3) 19,388 (3791) 	502 (3475)
c blood pressure; TM, treadmill; VO2, oxygen consumption; VT, ventilatory
cant difference between groups.
s from baseline to 12 weeks
E ANCOVA Peak MET ANCOVA
ange at
2 wks
F  3.690;
P  .042 Baseline
Change at
12 wks
F  5.804;
P  .011
.5 (6.9) .030 vs
controlb
4.31 (1.00) 1.18 (0.94) .025 vs
controlb
.3 (4.9) .013 vs
controlb
4.61 (1.75) 1.09 (0.72) .018 vs
controlb
.9 (4.7) 4.44 (1.43) 0.10 (0.89)
en consumption; VT, ventilatory threshold; VE, minute ventilation; MET,
ficant difference between groups.nd re
O2: P
L/-k
ne
.9)
.9)
.4)
D, pavari
BP, m
Cha
12
3.2
13.8
2.2
systoliiable
rcise V
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June 20111562 Bronas et alThe mean increase in the MWD for the arm-ergometer
and treadmill-walking groups were 181.1  127 meters
(43%) and 297.6 172meters (61%), respectively, vs 46.3
92.5 meters (13%) in the control group. There was a
significant difference in change in the mean MWD in the
arm-ergometer (P  .023) and the treadmill (P  .002)
groups compared with the control group, again with no
statistical difference observed between the two exercise
intervention groups.
Associations between changes in cardiorespiratory
function and walking distance. As reported in Table V, a
moderately significant inverse association was observed be-
tween change in the double product during stage 1 of the
exercise test and change in the PFWD in all three groups.
Moreover, there was a significant strong positive associa-
tion between the change in VO2 at the onset of claudica-
tion and change in both PFWD and MWD, as well as a
moderate association between the change in VO2 at the
ventilatory threshold and change in PFWD, and a strong
correlation with change in MWD. There were also strong
associations between changes in peak double product, VO2
peak, and in peak minute ventilation with the improve-
ments in both PFWD andMWD for the total study sample.
Peak heart rate was moderately associated with increased
PFWD and was strongly associated with MWD. Separate
subgroup analysis indicated similar associations across the
groups, albeit with a lower probability of significance due to
the reduction in power (data not shown).
DISCUSSION
To our knowledge, this is the first controlled study to
compare exercise-induced adaptations in hemodynamic
and cardiorespiratory functions between arm-ergometer
Table V. Associations between changes in selected
cardiorespiratory variables and changes in walking
improvement
Variable
PFWD MWD
r P r P
Submaximal DPa –0.43 .02 –0.26 .17
SubmaximalVO2
b 0.62 .001 0.32 .09
Cld1VO2
c 0.61 .001 0.67 .001
VTd 0.42 .02 0.68 .001
Peak DPe 0.28 .16 0.62 .001
Peak VO2
f 0.67 .001 0.62 .001
Peak VEg 0.65 .003 0.58 .001
Peak HRh 0.42 .02 0.68 .001
MWD, Maximal walking distance; PFWD, pain-free walking distance; r,
Pearson’s product moment correlation coefficient.
aChange in submaximal double product (DP; 2.0/0% grade).
bChange in submaximal oxygen consumption (VO2, 2.0 mph/0% grade).
cChange in oxygen consumption (VO2) at onset of claudication (Cldl) pain.
dChange in oxygen consumption (VO2) at the ventilatory threshold (VT).
eChange in peak double product (DP).
fChange in peak oxygen consumption (VO2).
gChange in peak minute ventilation (VE).
hChange in peak heart rate (HR).exercise training and treadmill-walking exercise training in dAD patients with claudication. Both exercise intervention
roups in this study improved their physical fitness and
alking ability to a similar extent. This is supportive of
imilar improved walking ability and physical fitness-
ssociated central cardiorespiratory functions in response to
ither form of exercise training in PAD patients with clau-
ication. Despite these findings, however, there was no
ssociated significant improvement in ABI observed across
roups nor any associations between improved MWD and
hanges in ABI, consistent with previously reported find-
ngs.11 The improvement in walking capacity observed in
he present study compares favorably with that reported in
revious studies involving arm-ergometry exercise training
n PAD patients with claudication.12,13,15
In contrast to previously postulated mechanisms to
xplain improved walking distance with treadmill exercise
raining, this study demonstrates that mechanisms in addi-
ion to improved distal limb blood flow or skeletal muscle
etabolic adaptations to intermittent ischemia contrib-
te to improved walking ability after exercise training in
AD patients with claudication, particularly the ob-
erved contribution of improved cardiorespiratory fitness
ith both arm-ergometry and treadmill-walking exercise
raining. Previous treadmill-walking studies postulated
hat the major limitations in VO2 peak, oxygen kinetics,
eak heart rate, and MWD in patients with PAD and claudi-
ation was “muscle mitochondrial myopathy” secondary to
ecreased distal limb blood flow and ischemic reperfusion
njury.9,10,21-25 If this hypothesis completely explained the
hysiologic limitation in walking distances and cardiorespira-
ory function in patients with claudication, it would not have
een anticipated that arm-ergometer exercise training could
mprove walking capacity in participants with claudication.
herefore, the findings in this study support the significant
ontribution by improved general physical conditioning, and
n associated improvement in the systemic cardiorespiratory
xygen delivery system and associated central cardiorespira-
ory functions to the improved walking ability in the arm-
rgometer group as well as in the treadmill-walking exercise
roup.
The findings in this study of an improvement in rate of
xygen consumption at the ventilatory thresholdwith exercise
raining in patients with claudication induced by PAD con-
rast with those of Tew et al,15 who did not observe a change
n ventilatory threshold after arm-ergometer exercise training.
owever, the training program used by Tew et al15 provided
much lower exercise training volume and intensity com-
ared with the present study, making comparisons between
tudy results difficult.
Further, the improvement observed in this study is
onsistent with data from a limited number of studies in
ealthy individuals that demonstrated that arm-ergometer
xercise training increases the rate of oxygen consumption
t the ventilatory threshold, suggesting improved aerobic
etabolism.26,27 Our findings also are compatible with the
ell-known exercise transfer effects that have been shown
o occur in sedentary individuals with low fitness levels,
uring either maximal cycle ergometer or treadmill testing,
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Volume 53, Number 6 Bronas et al 1563after arm-ergometer exercise training.26-29 Thus, exercise
training of upper body muscle groups appears to result in
a generalized systemic training effect that can improve
exercise capacity of muscle groups not participating in
the training effort. It is also plausible that the arm-
ergometry group experienced a greater stimulus for car-
diorespiratory improvement than the treadmill group
because the arm-ergometer group was limited by cardio-
respiratory capacity or arm fatigue rather than by claudi-
cation pain.
The findings of significant associations between
changes in submaximal exercise and peak exercise fitness
parameters and improvement in walking distances with
both forms of exercise training are consistent with those of
previously published reports.5,10,12,13,30 These findings
suggest that improved central cardiorespiratory fitness with
both arm-ergometer and lower body-exercise training de-
fers the onset of claudication pain during walking in PAD
patients and contributes significantly to improved MWD.
The observed improvement of walking distances after exer-
cise training was previously postulated to be related to local
skeletal muscle metabolic changes, improved vascular en-
dothelial reactivity, blood rheologic changes, and local and
central blood flow adaptations.11 Although such adapta-
tions likely contribute to improvement in walking capacity,
the strong associations found in the present study between
improved central cardiorespiratory fitness parameters and
changes in walking distance suggest that this is another
significant contributing mechanism to improved walking
ability after both arm-ergometer and treadmill-walking ex-
ercise training.
Limitations and implications for future studies.
This study was originally designed and funded as a pilot
study, so a major limitation is the relatively small sample
size. Future studies are needed to more fully elucidate the
optimal training dose as well as mechanisms for improved
walking distance after both arm-ergometry and treadmill-
walking (or possibly a combination) exercise training across
the spectrum of PAD.
Another limitation was absence of measurements to
determine additional mechanisms contributing to ob-
served improvement in walking ability; for example,
assessment of changes in cardiac output, vascular endo-
thelial function and inflammation, and muscle biopsy
metabolic measurements. Future studies that include
these measurements would greatly improve understand-
ing of systemic and local skeletal muscle adaptations to
exercise training. Future exercise training studies should
also investigate changes in cardiovascular disease risk
factors, including long-term cardiovascular disease mor-
bidity and mortality, and relative cost-effectiveness com-
parisons.
Other limitations included the potential for confound-
ing variables associated with medical comorbidities in this
patient population. However, to reduce variability in re-
sponses due to comorbidities, attempts were made in this
study to ensure that only participants were enrolled whose
1alking ability and physical fitness level were limited pri-
arily by claudication.
ONCLUSIONS
Arm-ergometer exercise training appears to be an effec-
ive form of intervention for improving physical fitness,
entral cardiorespiratory function, and walking capacity in
atients with PAD-induced claudication. The findings in
he present study of associations between improved general
hysical conditioning variables and associated central car-
iorespiratory variables and improved walking ability in
AD patients with claudication after either form of exercise
raining suggest a greater contribution of central cardiore-
piratory adaptations to improvement in walking ability
han previously realized. Confirmation of these findings
ith a larger study sample and additional cardiovascular
nd metabolic measurements are warranted to better un-
erstand the mechanisms contributing to improved walk-
ng ability after exercise training in PAD patients with
laudication.
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